AIM
AGTC

Acrospire Investment Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Acrospire Investment Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,661
Closed -$46K – 2641
2017
Q1 		$46K Buy
+6,661
New +$52K 0.04% 1034
2016
Q4 		– Sell
-23,743
Closed -$232K – 2477
2016
Q3 		$232K Buy
23,743
+7,800
+49% +$105K 0.15% 88
2016
Q2 		$225K Buy
15,943
+1,842
+13% +$28.7K 0.17% 39
2016
Q1 		$197K Buy
+14,101
New +$207K 0.14% 187

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acrospire Investment Management's AGTC Position: Q2 2017 in Review

Acrospire Investment Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2017, closing a stake of 6,661 shares — an estimated $46K sold.

Acrospire Investment Management first reported a position in AGTC in Q1 2016 and held it in 4 quarters. The position peaked at $232K in Q3 2016. 77 funds tracked by Wall St. Rank hold AGTC as of Q2 2017.

  • Acrospire Investment Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 6,661 Applied Genetic Technologies Corporation shares in Q2 2017, an estimated $46K.
  • Acrospire Investment Management first reported a position in Applied Genetic Technologies Corporation in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Applied Genetic Technologies Corporation position peaked at $232K in Q3 2016.
  • 77 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.